Well think of it this way, what if Vascepa gets ANCHOR and therefore, gets most of the Generic Lovaza scripts, as they should... What would 50,000 scripts per week do to the share price?
At a low ball $100 per script, that is 260,000,000 revenue per year. 390M at $150 per script
Market Data 
Markets 
AI
